The fund will be led by Adam Koppel, who rejoined the firm this year from biotechnology company Biogen, and Jeff Schwartz, who moves over from Bain’s private equity team.
Tag Archives | life sciences
German venture capital-backed cancer drug maker Ganymed Pharmaceuticals has been acquired by Japanese pharma company Astellas Pharma for €422 million.
A consortium including the venture arm of Google parent company Alphabet has backed life-sciences startup Genomics Medicine Ireland in a $40 million Series A round of financing.
Californian biotech investor Sofinnova Ventures has closed its tenth fund on its hard cap of $650 million, exceeding its $550 million target.
New Enterprise Associates led the round in Relievant Medsystems with participation from Emergent Medical Partners, Canaan Partners and Morgenthaler Ventures.
Californian venture firm General Catalyst has led a $45M investment in genetic testing company Color Genomics, a round also supported by the singer Bono.
A venture capital consortium including Forbion Capital Partners has sold molecular therapauetics company Arkana to Allergan for $50 million, the pharmaceutical giant’s third purchase of a VC-backed company this month.
California’s SDL Ventures and Russian firm RBV Capital were among investors exiting RetroSense Therapeutics, which has been sold to Allergan for $60m.
UK technology investor Amadeus Capital Partners has taken a 20 percent stake in Igenomix, an in-vitro fertilisation genetic testing company owned by Italian private equity firm Charme Capital Partners.
William Salisbury will work with the growth equity firm’s portfolio companies in his new role as CFO and operating partner.